E
Bluejay Diagnostics, Inc.
BJDX
$4.03
$0.000.00%
E
Sell
3/5/2025Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 3/5/2025 due to a decline in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 3/5/2025 due to a decline in the volatility index.
E
Sell
2/18/2025Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 2/18/2025 due to an increase in the volatility index and total return index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 2/18/2025 due to an increase in the volatility index and total return index.
E
Sell
12/3/2024Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 12/3/2024 due to a decline in the volatility index and total return index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 12/3/2024 due to a decline in the volatility index and total return index.
E
Sell
11/18/2024Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 11/18/2024 due to an increase in the volatility index and solvency index. The quick ratio increased from 3.92 to 5.49, and debt to equity declined from 0.03 to 0.02.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 11/18/2024 due to an increase in the volatility index and solvency index. The quick ratio increased from 3.92 to 5.49, and debt to equity declined from 0.03 to 0.02.
E
Sell
6/27/2024Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 6/27/2024 due to a decline in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 6/27/2024 due to a decline in the volatility index.
E
Sell
6/12/2024Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 6/12/2024 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.856 to -$0.9869, and operating cash flow increased 17.33% from -$2.78M to -$2.3M.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 6/12/2024 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.856 to -$0.9869, and operating cash flow increased 17.33% from -$2.78M to -$2.3M.
E
Sell
5/22/2024Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 5/22/2024 due to a decline in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 5/22/2024 due to a decline in the volatility index.
E
Sell
5/7/2024Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 5/7/2024 due to an increase in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 5/7/2024 due to an increase in the volatility index.
E
Sell
3/13/2024Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 3/13/2024 due to a decline in the volatility index and total return index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 3/13/2024 due to a decline in the volatility index and total return index.
E
Sell
2/26/2024Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 2/26/2024 due to an increase in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E+ from E on 2/26/2024 due to an increase in the volatility index.
E
Sell
2/6/2024Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 2/6/2024 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 2.78 to 1.81.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E from E+ on 2/6/2024 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 2.78 to 1.81.
E
Sell
3/17/2023Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 3/17/2023 due to a decline in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 3/17/2023 due to a decline in the volatility index.
D
Sell
3/2/2023Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 3/2/2023 due to an increase in the volatility index and total return index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 3/2/2023 due to an increase in the volatility index and total return index.
E
Sell
2/9/2023Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 2/9/2023 due to a decline in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 2/9/2023 due to a decline in the volatility index.
D
Sell
1/25/2023Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 1/25/2023 due to an increase in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 1/25/2023 due to an increase in the volatility index.
E
Sell
1/4/2023Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 1/4/2023 due to a decline in the volatility index and total return index.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 1/4/2023 due to a decline in the volatility index and total return index.
D
Sell
12/6/2022Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 12/6/2022 due to an increase in the volatility index.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E+ on 12/6/2022 due to an increase in the volatility index.
E
Sell
11/16/2022Downgrade
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 11/16/2022 due to a major decline in the efficiency index, growth index and volatility index. Earnings per share declined from -$0.0961 to -$0.1469, net income declined 52.78% from -$1.94M to -$2.96M, and EBIT declined 41.52% from -$1.99M to -$2.81M.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E+ from D- on 11/16/2022 due to a major decline in the efficiency index, growth index and volatility index. Earnings per share declined from -$0.0961 to -$0.1469, net income declined 52.78% from -$1.94M to -$2.96M, and EBIT declined 41.52% from -$1.99M to -$2.81M.
D
Sell
8/1/2022Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E on 8/1/2022 due to a large increase in the efficiency index, growth index and volatility index. Operating cash flow increased 25.59% from -$2.52M to -$1.88M.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to D- from E on 8/1/2022 due to a large increase in the efficiency index, growth index and volatility index. Operating cash flow increased 25.59% from -$2.52M to -$1.88M.
E
Sell
5/1/2022Upgraded
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E from E- on 5/1/2022 due to a significant increase in the solvency index and valuation index. The quick ratio increased from 0.5 to 29.89.
Bluejay Diagnostics, Inc. (BJDX) was upgraded to E from E- on 5/1/2022 due to a significant increase in the solvency index and valuation index. The quick ratio increased from 0.5 to 29.89.
E
Sell
2/7/2022None
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E- from U on 02/07/2022.
Bluejay Diagnostics, Inc. (BJDX) was downgraded to E- from U on 02/07/2022.
NASDAQ
03/12/2025 3:05PM Eastern
Quotes delayed
